{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:59:35Z","timestamp":1756573175153,"version":"3.30.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1004498","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:25:52Z","timestamp":1733855152000},"page":"e1004498","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protecting the most vulnerable: The urgent need to include HIV-exposed children in malaria chemoprevention strategies"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-801X","authenticated-orcid":true,"given":"Raquel","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-8752","authenticated-orcid":true,"given":"Tacilta","family":"Nhampossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-1421","authenticated-orcid":true,"given":"Ant\u00eda","family":"Figueroa-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9-Marie","family":"Tchouatieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-0599","authenticated-orcid":true,"given":"Christine","family":"Manyando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"pmed.1004498.ref001","volume-title":"World malaria report 2023.","author":"WHO","year":"2023"},{"issue":"4","key":"pmed.1004498.ref002","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/S2352-3018(24)00035-3","article-title":"Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps","volume":"11","author":"A Figueroa-Romero","year":"2024","journal-title":"Lancet HIV"},{"issue":"10","key":"pmed.1004498.ref003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1468-1293.2012.01018.x","article-title":"High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey.","volume":"13","author":"R Gonzalez","year":"2012","journal-title":"HIV Med."},{"key":"pmed.1004498.ref004","unstructured":"WHO. Mother-to-child transmission of HIV. Global HIV Progamme. 2023. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/mother-to-child-transmission-of-hiv [cited 2024 Jan 15]."},{"issue":"5","key":"pmed.1004498.ref005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/COH.0000000000000300","article-title":"Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers","volume":"11","author":"S Desmonde","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"pmed.1004498.ref006","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.aids.0000200533.56490.b7","article-title":"Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria","volume":"20","author":"RO Otieno","year":"2006","journal-title":"AIDS (London, England)."},{"key":"pmed.1004498.ref007","unstructured":"WHO. WHO Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. 2010."},{"key":"pmed.1004498.ref008","unstructured":"WHO. Guidelines for malaria. 2022."},{"key":"pmed.1004498.ref009","unstructured":"ISGlobal. MULTIPLY project. Available from: https:\/\/multiplyipti.net\/ [cited 2024 May 9]. 2024."},{"key":"pmed.1004498.ref010","unstructured":"PSI. Plus Project. Available from: https:\/\/www.psi.org\/plusproject\/home\/ [cited 2024 May 9]. 2024."},{"issue":"6","key":"pmed.1004498.ref011","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","article-title":"Safety and toxicity of sulfadoxine\/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.","volume":"30","author":"PJ Peters","year":"2007","journal-title":"Drug Saf."},{"key":"pmed.1004498.ref012","volume-title":"Consolidated guidelines on the Use of Antiretroviral Drugs for treating and Preventing HIV infection. Recommendations for a public health approach.","author":"WHO","year":"2013"},{"key":"pmed.1004498.ref013","unstructured":"WHO. Provisional WHO\/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV\/AIDS in Africa. 2000."},{"issue":"9163","key":"pmed.1004498.ref014","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","article-title":"Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d\u2019Ivoire: a randomised trial. Cotrimo-CI Study Group","volume":"353","author":"X Anglaret","year":"1999","journal-title":"Lancet"},{"issue":"9448","key":"pmed.1004498.ref015","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","article-title":"Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.","volume":"364","author":"C Chintu","year":"2004","journal-title":"Lancet"},{"issue":"15","key":"pmed.1004498.ref016","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0b013e3282ef6da1","article-title":"Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children","volume":"21","author":"MR Kamya","year":"2007","journal-title":"AIDS"},{"issue":"1","key":"pmed.1004498.ref017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAD.0b013e3280114ed7","article-title":"Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children","volume":"21","author":"V Mulenga","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"pmed.1004498.ref018","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cid\/cir413","article-title":"Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi","volume":"53","author":"TE Taha","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pmed.1004498.ref019","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/QAD.0b013e32835ca29f","article-title":"Health outcomes of HIV-exposed uninfected African infants","volume":"27","author":"AP Kourtis","year":"2013","journal-title":"AIDS"},{"issue":"8","key":"pmed.1004498.ref020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/INF.0b013e31825c124a","article-title":"Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.","volume":"31","author":"A Dow","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"pmed.1004498.ref021","doi-asserted-by":"crossref","first-page":"e56916","DOI":"10.1371\/journal.pone.0056916","article-title":"Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.","volume":"8","author":"C Manyando","year":"2013","journal-title":"PLoS ONE."},{"issue":"5","key":"pmed.1004498.ref022","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/cit806","article-title":"Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial","volume":"58","author":"E Klement","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pmed.1004498.ref023","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1016\/S2214-109X(14)70329-8","article-title":"Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial","volume":"2","author":"J Homsy","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10","key":"pmed.1004498.ref024","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1473-3099(07)70239-6","article-title":"Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries","volume":"7","author":"R Zachariah","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pmed.1004498.ref025","doi-asserted-by":"crossref","first-page":"e1002014","DOI":"10.1371\/journal.pmed.1002014","article-title":"A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected.","volume":"13","author":"R Gonzalez","year":"2016","journal-title":"PLoS Med."},{"key":"pmed.1004498.ref026","unstructured":"WHO. WHO Expert Committee on Malaria. Twentieth Report. World Health Organization Geneva. 1998. Available from: https:\/\/iris.who.int\/handle\/10665\/42247 [cited 2024 May 9]."},{"issue":"9","key":"pmed.1004498.ref027","doi-asserted-by":"crossref","first-page":"e1001735","DOI":"10.1371\/journal.pmed.1001735","article-title":"Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial.","volume":"11","author":"R Gonzalez","year":"2014","journal-title":"PLoS Med."},{"key":"pmed.1004498.ref028","article-title":"Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial","author":"R Gonz\u00e1lez","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10424","key":"pmed.1004498.ref029","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(23)02631-4","article-title":"Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial","volume":"403","author":"HC Barsosio","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"pmed.1004498.ref030","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01310-18","article-title":"Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine","volume":"63","author":"SI Walimbwa","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:26:02Z","timestamp":1733855162000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004498","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}